TransPrEP! HIV Prevention for Transgender Persons in California
Premiere Date: 12/8/2017; 4 minutes


Copy the following code and paste it into your web page to embed this video:

The California HIV/AIDS Research Program (CHRP) is funding the largest demonstration project of its kind in theUS, to determine the acceptability, utilization, adherence, and pharmacokinetics of HIV pre-exposure prophylaxis (PrEP) medication among transgender persons to promote their health and protect their lives. As researchers, participants and healthcare providers explain here, the three CHRP-supported studies across the state use different techniques, such as providing PrEP and hormonal therapy together at a single clinic visit, offering in-depth pharmacokinetic analyses on how the two treatments interact, or creating a custom text messaging app to communicate with providers and offer peer support. Information on how to enroll in the University of California-affiliated studies is included. (#33176)


Sign up for UCTV's monthly e-newsletter:
contact
contact info

feedback

press

watch
where to watch

videos & podcasts

live stream

retransmission

more info
about uctv

faqs

program contributors

university of california

sitemap

follow



©2016 Regents of the University of California. All right reserved. Terms and Conditions of Use.